Me, once valued at $6 billion, is now a penny stock. Layoffs, data breaches, and resignations led to its downfall. How did it ...

Me (ME) gained 3% after its CEO Anne Wojcicki made a non-binding revised offer of $2.94 a share for the genetic testing ...

Experts say the CEO’s second attempt to buy back the troubled DNA startup comes with a slew of corporate governance red flags ...

The genetic testing giant's CEO just made a desperate $2.94/share bid--after its stock cratered 99%. Will the board bite?

23andMe is a company on the ropes. The one-time leader of the DNA analysis market – valued at $6 billion in 2021 – is now ...

The latest plan by 23andMe co-founder and CEO Anne Wojcicki to acquire the genetic testing company was rejected by a special ...

Me’s special committee of independent directors on Monday rejected CEO Anne Wojcicki’s proposal to take the distressed ...

SUNNYVALE, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- The Special Committee of the Board of Directors of 23andMe Holding Co. ...

23andMe CEO Anne Wojcicki is attempting to buy her company back for a mere $42 million. It’s a fraction of the company’s ...

Me (ME) stock nosedived over 33% yesterday after the board unanimously rejected CEO Anne Wojcicki’s takeover offer. The company has set up ...